RAC 0.00% $1.61 race oncology ltd

Ann: December 2023 Preclinical & Clinical Program Update, page-42

  1. 510 Posts.
    lightbulb Created with Sketch. 183
    Hi@Davisite

    Are we likely to see any data from the Phase 1a/b Trial of RC220 in 2024 ?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.